Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) Other Operating Expenses (2025)

Historic Other Operating Expenses for Zenas BioPharma (ZBIO) over the last 1 years, with Q3 2025 value amounting to $5.0 million.

  • Zenas BioPharma's Other Operating Expenses changed N/A to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Zenas BioPharma reported Other Operating Expenses of $5.0 million as of Q3 2025.
  • Zenas BioPharma's Other Operating Expenses' 5-year high stood at $5.0 million during Q3 2025, with a 5-year trough of $5.0 million in Q3 2025.